{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:47:58Z","timestamp":1794012478047,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["3627036"],"award-info":[{"award-number":["3627036"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["JXU058"],"award-info":[{"award-number":["JXU058"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000561","name":"British Science Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["3338701"],"award-info":[{"award-number":["3338701"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007879","name":"Tertiary Education Commission","doi-asserted-by":"publisher","award":["9341-3622506"],"award-info":[{"award-number":["9341-3622506"]}],"id":[{"id":"10.13039\/100007879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3456030"],"award-info":[{"award-number":["3456030"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3627092"],"award-info":[{"award-number":["3627092"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3701339"],"award-info":[{"award-number":["3701339"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3702870"],"award-info":[{"award-number":["3702870"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3703253"],"award-info":[{"award-number":["3703253"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/LO10445\/1"],"award-info":[{"award-number":["MR\/LO10445\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["UOAX0815"],"award-info":[{"award-number":["UOAX0815"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006500","name":"Cure Huntington's Disease Initiative","doi-asserted-by":"publisher","award":["A-8247"],"award-info":[{"award-number":["A-8247"]}],"id":[{"id":"10.13039\/100006500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ebiom.2023.104824","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:46:45Z","timestamp":1696931205000},"page":"104824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-0986","authenticated-orcid":false,"given":"Melissa","family":"Scholefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Patassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-3163","authenticated-orcid":false,"given":"Garth J.S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2023.104824_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2019.0423","article-title":"Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts","volume":"76","author":"Gardiner","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2023.104824_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104824_bib3","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington's disease: an updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104824_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: an evolving and intricate story","volume":"69","author":"Rosas","year":"2012","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuroimage.2012.07.009","article-title":"Increased brain tissue sodium concentration in Huntington's disease - a sodium imaging study at 4 T","volume":"63","author":"Reetz","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ebiom.2023.104824_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nbd.2014.06.022","article-title":"Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model","volume":"71","author":"Lu","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104824_bib7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/hbm.22391","article-title":"MRI measures of corpus callosum iron and myelin in early Huntington's disease","volume":"35","author":"Di Paola","year":"2014","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104824_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104824_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuroimage.2012.03.056","article-title":"Elevated brain iron is independent from atrophy in Huntington's disease","volume":"61","author":"Dumas","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hbm.22612","article-title":"The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study","volume":"36","author":"Sanchez-Castaneda","year":"2015","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104824_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib12","first-page":"153","article-title":"Standardizing the CAP score in Huntington's disease by predicting age-at-onset","volume":"11","author":"Warner","year":"2022","journal-title":"J\u00a0Huntingtons Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104824_bib13","first-page":"217","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J\u00a0Huntingtons Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-019-00086-y","article-title":"Rutin and selenium Co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington's disease","volume":"37","author":"Abdelfattah","year":"2020","journal-title":"Neurotox Res"},{"key":"10.1016\/j.ebiom.2023.104824_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jtemb.2019.09.006","article-title":"Trace elements profile in the blood of Huntington' disease patients","volume":"57","author":"Squadrone","year":"2020","journal-title":"J\u00a0Trace Elem Med Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12011-018-1302-5","article-title":"Prevention of keshan disease by selenium supplementation: a systematic review and meta-analysis","volume":"186","author":"Zhou","year":"2018","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11596-019-2025-3","article-title":"Efficacy of long-term selenium supplementation in the treatment of chronic Keshan disease with congestive heart failure","volume":"39","author":"Zhu","year":"2019","journal-title":"Curr Med Sci"},{"issue":"38","key":"10.1016\/j.ebiom.2023.104824_bib19","doi-asserted-by":"crossref","first-page":"34725","DOI":"10.1021\/acsami.9b12319","article-title":"Selenium nanoparticles as an efficient nanomedicine for the therapy of Huntington's disease","volume":"11","author":"Cong","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104824_bib20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/nu10101466","article-title":"Selenium analysis and speciation in dietary supplements based on next-generation selenium ingredients","volume":"10","author":"Constantinescu-Aruxandei","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ebiom.2023.104824_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8653132","article-title":"Neuroimmunology of Huntington's disease: revisiting evidence from human studies","volume":"2016","author":"Rocha","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ca.23792","article-title":"Apoptosis and its therapeutic implications in neurodegenerative diseases","volume":"35","author":"Erekat","year":"2022","journal-title":"Clin Anat"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104824_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104824_bib25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/antiox10091407","article-title":"In\u00a0vivo brain GSH: MRS methods and clinical applications","volume":"10","author":"Bottino","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104824_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1079\/BJN20041110","article-title":"Selenium and iodine intakes and status in New Zealand and Australia","volume":"91","author":"Thomson","year":"2004","journal-title":"Br J Nutr"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104824_bib27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archneur.1986.00520120056016","article-title":"Cerebral cation shifts and amino acids in Huntington's disease","volume":"43","author":"Gramsbergen","year":"1986","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.410040111","article-title":"Increased sodium plus potassium adenosine triphosphatase activity in erythrocyte membranes in Huntington's disease","volume":"4","author":"Butterfield","year":"1978","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0028-3886.32797","article-title":"Endogenous sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: neural regulation of genomic function","volume":"50","author":"Kumar","year":"2002","journal-title":"Neurol India"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104824_bib30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib31","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104824_bib32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","article-title":"Striatal hypometabolism in premanifest and manifest Huntington's disease patients","volume":"43","author":"Lopez-Mora","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104824_bib33","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104824_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104824_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104824_bib36","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ebiom.2023.104824_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7580707","article-title":"The essential element manganese, oxidative stress, and metabolic diseases: links and interactions","volume":"2018","author":"Li","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104824_bib38","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","article-title":"The molecular mechanisms of copper metabolism and its roles in human diseases","volume":"472","author":"Chen","year":"2020","journal-title":"Pflugers Arch"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104824_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/fcp.12110","article-title":"Zinc: indications in brain disorders","volume":"29","author":"Prakash","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104824_bib40","article-title":"Insight into glutamate excitotoxicity from synaptic zinc homeostasis","volume":"2011","author":"Takeda","year":"2010","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03033574","article-title":"Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus","volume":"14","author":"Youdim","year":"2008","journal-title":"Neurotox Res"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104824_bib42","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.1519473113","article-title":"Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice","volume":"113","author":"Matak","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14169-y","article-title":"Alterations in metal homeostasis occur prior to canonical markers in Huntington disease","volume":"12","author":"Pfalzer","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104824_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuro.2021.09.002","article-title":"YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes","volume":"87","author":"Wilcox","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ebiom.2023.104824_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173337","article-title":"Manganese-induced hyperactivity and dopaminergic dysfunction depend on age, sex and YAC128 genotype","volume":"213","author":"Wilcox","year":"2022","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104824_bib46","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1039\/d0mt00081g","article-title":"Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice","volume":"12","author":"Pfalzer","year":"2020","journal-title":"Metallomics"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104824_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250606","article-title":"Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease","volume":"16","author":"Donley","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104824_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13311-019-00785-6","article-title":"Brain zinc deficiency exacerbates cognitive decline in the R6\/1 model of Huntington's disease","volume":"17","author":"Ayton","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebiom.2023.104824_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.641222","article-title":"Widespread decreases in cerebral copper are common to Parkinson's disease dementia and alzheimer's disease dementia","volume":"13","author":"Scholefield","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104824_bib50","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1039\/C7MT00074J","article-title":"Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia","volume":"9","author":"Xu","year":"2017","journal-title":"Metallomics"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104824_bib51","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ajcn\/84.4.762","article-title":"Selenium and coronary heart disease: a meta-analysis","volume":"84","author":"Flores-Mateo","year":"2006","journal-title":"Am J Clin Nutr"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:29:05Z","timestamp":1762457345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"alternative-id":["S2352396423003900"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104824","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104824"}}